Loading insider details...
Beta
Latest Form 4 (Jun 26, 2026): Grant/Award of 62,000 CCCC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 26, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 62,000 | n/a |
| Jun 20, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 35,500 | n/a |
| Jun 21, 2024 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 32,500 | n/a |
| Jun 16, 2023 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 26,000 | n/a |
| Mar 6, 2023 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 6,871 | $24.9K |
| Feb 10, 2023 | C4 Therapeutics, Inc. (CCCC) | Purchase | 5,667 | $31.7K |
| Feb 9, 2023 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 2,485 | $13.6K |
| Nov 19, 2022 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 5,172 | $23.2K |
| Aug 18, 2022 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 5,940 | $29.9K |
| Jun 10, 2022 | Atara Biotherapeutics, Inc. (ATRA) | Sale | 5,853 | $33.0K |